“After the last two decades of consumer Internet and mobile innovation, is biotech or bioinformatics the next wave?
There are a handful of San Francisco-based startups that cross the bridge between the worlds of biotechnology and computer science.
Benchling is one of them.
Backed with about $900,000 from YCombinator, SV Angel, Founders Fund’s angel investing fund, Draper Associates and other angels, the company offers DNA editing and analysis software to biotech labs and researchers. With the entire team coming from MIT with skills in both computer science and biology, they’re competing against older, more cumbersome software solutions in the space.”